cMeA.com
About CMEA Capital
A venture capital company with interests in energy and materials, information technology, and the life sciences, CMEA Capital focuses on building relationships with innovative companies and entrepreneurs. The firm strives for a mutually beneficial arrangement that facilitates the growth of client companies and development ideas while providing return for investors. Toward this end, CMEA Capital searches continuously for new discoveries and promising projects that are likely to have a significant impact on the scientific and medical communities. In the field of medicine, CMEA Capital has invested in medical devices, diagnostic technology, and new pharmaceuticals.
CMEA Capital also channels capital into new Internet technologies and technology software, as well as projects and research in the field of alternative energy. The firm's executive team selects only the most promising companies that can demonstrate their intent to create value from investments. Two such companies, Velocity Pharmaceutical Development and Tigercat Pharma, have used CMEA investments to develop a new drug to treat chronic pruritus, or itchiness, which disturbs sleep and daily life for six months or more. The company seeks out opportunities to fund projects like this, which have a real impact on people and the planet.
